ELIZABETH HOLCOMBE ADAMS

Allopathic & Osteopathic Physicians|Emergency Medicine BIRMINGHAM, AL NPI 1013236975

General Payments — all program years on this page

$567.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $302.72 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $302.7211

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
REVANCE THERAPEUTICS, INC. $156.503
Galderma Laboratories, L.P. $108.906
ABBVIE INC. $37.322

By program year

Program yearAmountRecords
2018 $42.063
2019 $14.151
2020 $12.571
2022 $16.451
2023 $179.6810
2024 $302.7211

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103929952 ABBVIE INC. $23.72 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103929954 ABBVIE INC. $13.60 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145304419 Galderma Laboratories, L.P. $19.31 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145304421 Galderma Laboratories, L.P. $17.54 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145304423 Galderma Laboratories, L.P. $17.65 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145304425 Galderma Laboratories, L.P. $15.69 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145304427 Galderma Laboratories, L.P. $23.75 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145304429 Galderma Laboratories, L.P. $14.96 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147920246 REVANCE THERAPEUTICS, INC. $133.52 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147920248 REVANCE THERAPEUTICS, INC. $5.81 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147920250 REVANCE THERAPEUTICS, INC. $17.17 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.